Sanofi Consumer Healthcare India Limited(IN:SANOFICONR)
₹3,528.50+2.55 (+0.07%)
IN:SANOFICONR
Sanofi Consumer Healthcare India Limited financials statements
₹3,528.50
At close:+2.55 (+0.07%)
Sanofi Consumer Healthcare India Limited (SANOFICONR) Ratios
2 Followers
Sanofi Consumer Healthcare India Limited Ratios
IN:SANOFICONR's free cash flow for Q4 2025 was ₹1.56B. For the 2025 fiscal year, IN:SANOFICONR's free cash flow was decreased by ₹-7.00M and operating cash flow was ₹1.57B. See a summary of the company’s cash flow.
| Ratios | Dec 25 |
|---|---|
| Liquidity Ratios | |
| Current Ratio | 3.85 |
| Quick Ratio | 3.37 |
| Cash Ratio | 2.92 |
| Solvency Ratio | 1.54 |
| Operating Cash Flow Ratio | 1.46 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Net Current Asset Value | ₹ 3.31B |
| Leverage Ratios | |
| Debt-to-Assets Ratio | 0.05 |
| Debt-to-Equity Ratio | 0.06 |
| Debt-to-Capital Ratio | 0.06 |
| Long-Term Debt-to-Capital Ratio | 0.00 |
| Financial Leverage Ratio | 1.42 |
| Debt Service Coverage Ratio | 126.90 |
| Interest Coverage Ratio | 148.65 |
| Debt to Market Cap | 0.00 |
| Interest Debt Per Share | 11.64 |
| Net Debt to EBITDA | -1.05 |
| Profitability Margins | |
| Gross Profit Margin | 57.81% |
| EBIT Margin | 36.69% |
| EBITDA Margin | 38.02% |
| Operating Profit Margin | 33.85% |
| Pretax Profit Margin | 36.46% |
| Net Profit Margin | 27.33% |
| Continuous Operations Profit Margin | 27.33% |
| Net Income Per EBT | 74.96% |
| EBT Per EBIT | 107.74% |
| Return on Assets (ROA) | 43.89% |
| Return on Equity (ROE) | 62.53% |
| Return on Capital Employed (ROCE) | 71.02% |
| Return on Invested Capital (ROIC) | 52.28% |
| Return on Tangible Assets | 43.96% |
| Earnings Yield | 2.30% |
| Efficiency Ratios | |
| Receivables Turnover | 29.58 |
| Payables Turnover | 4.66 |
| Inventory Turnover | 5.99 |
| Fixed Asset Turnover | 25.03 |
| Asset Turnover | 1.61 |
| Working Capital Turnover Ratio | 0.00 |
| Cash Conversion Cycle | -5.09 |
| Days of Sales Outstanding | 12.34 |
| Days of Inventory Outstanding | 60.96 |
| Days of Payables Outstanding | 78.40 |
| Operating Cycle | 73.31 |
| Cash Flow Ratios | |
| Operating Cash Flow Per Share | 81.64 |
| Free Cash Flow Per Share | 78.34 |
| Dividend Paid and CapEx Coverage Ratio | 1.40 |
| Capital Expenditure Coverage Ratio | 24.74 |
| Operating Cash Flow Coverage Ratio | 7.58 |
| Operating Cash Flow to Sales Ratio | 0.21 |
| Free Cash Flow Yield | 1.73% |
| Valuation Ratios | |
| Price-to-Earnings (P/E) Ratio | 43.41 |
| Price-to-Sales (P/S) Ratio | 11.87 |
| Price-to-Book (P/B) Ratio | 27.14 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 57.78 |
| Price-to-Operating Cash Flow Ratio | 55.44 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 |
| Enterprise Value Multiple | 30.16 |
| Enterprise Value | 100.72B |
| EV to EBITDA | 30.16 |
| EV to Sales | 11.47 |
| EV to Free Cash Flow | 55.83 |
| EV to Operating Cash Flow | 53.58 |
| Tangible Book Value Per Share | 166.41 |
| Shareholders’ Equity Per Share | 166.76 |
| Tax and Other Ratios | |
| Effective Tax Rate | 0.25 |
| Revenue Per Share | 381.47 |
| Net Income Per Share | 104.27 |
| Tax Burden | 0.75 |
| Interest Burden | 0.99 |
| Research & Development to Revenue | 0.00 |
| SG&A to Revenue | 0.24 |
| Stock-Based Compensation to Revenue | 0.00 |
| Income Quality | 0.78 |
Currency in INR

